Healthcare Portfolio Management Services | Lifescience, Pharma, Biotech Portfolio Management Services
Matching Competencies and vision to develop a strong portfolio for future gains
Shrinking pipelines, lack of innovative ideas, increased cost of therapy development, regulatory pressures, reimbursement issues, and stagnation in revenue through previous innovative therapy sales- these are some of the major issues plaguing the Pharma sector and are also reasons which are forcing these companies to rethink their clinical developmental strategy to meet corporate goals.
There is an issue in not being able to understand which areas of focus might or might not align with the vision of the company, depleting valuable resources of the company that could otherwise be utilized on something that may prove to be beneficial in the future.
A major aspect to be considered here is to understand one’s core competencies, assess the assets and products that can be managed with those core competencies and then understand the bounds of one’s developmental and commercial aspects.
Portfolio management not only includes assessment of products whose development might be beneficial for company’s future growth, but also aligns the competencies of the company with the vision of the company, creating a positive organizational culture and potent workforce.
DelveInsight’s Portfolio Management services provides unmatched assistance in understanding your competencies, leverage strengths to prioritize strategic goals, understand the current needs of the market and likewise work on creating value for the customers, as well as for the company.
Our Portfolio Management methodology provides:
Define goals of the company to segregate priorities
List probable avenues of Organizational Success
Assess Potential Changes in the Industry
Understanding needs of the End user
Channelize strengths to improve strategy
Implement resource and cost saving processes
CDMO Competitive Assessment in the USA and Europe
A CDMO client based in Europe, involved DelveInsight to provide in-depth competitor assessment of companies active in the pharma CDMO area, in order to understand effective landscaping and conduct strategic decision-making for gaining competitive advantage. [...]